Latest Breaking News On - Cting lexx us52886n4060 - Page 1 : comparemela.com

Item 1.0 Entry into a Material Definitive Agreement Lexaria Bioscience Corp. entered into a Master Services Agreement with InClin, Inc. for the purposes of InClin acting as Lexaria s clinical. | May 12, 2023

Inclin incLexaria bioscience corpDrug administrationMaster services agreementMaterial definitiveInvestigational new drugClinical trial agreementsEdgar onlineLexaria bioscience corp stock exchangePress releaseCting lexx us52886n4060